Document is current
Any future updates will be listed below
-
Authors
Ghanian, Soha
Yamanaka-Takaichi, Mika
Naik, Haley B.
Alavi, Afsaneh
- License Information
-
More Information
Article History
Accepted: 8 December 2021
First Online: 6 January 2022
Declarations
:
: No sources of funding were used to assist in the preparation of this manuscript.
: Soha Ghanian, Mika Yamanaka-Takaichi, and Haley B. Naik have no conflicts of interest to disclose. Afsaneh Alavi is a consultant for Abbvie, Boehringer Ingelheim, Janssen, InflaRx, Novartis, and UCB.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: SG and MYT performed the literature review, and MYT, HBN, and AA edited the manuscript.
